Table 1.
Characteristic | All participants N=6256 |
---|---|
Age, median [IQR] | 12.21 [7.87–21.28] |
Male sex, n (%) | 3038 (48.6) |
Number of AAbs, n (%) | |
0 | 180 (2.9) |
1 | 2470 (39.5) |
2 | 1451 (23.2) |
3 | 963 (15.4) |
4 | 741 (11.8) |
5 | 451 (7.2) |
Type of AAb, n (%) | |
GAD65+ | 4955 (79.2) |
IA-2+ | 1900 (30.4) |
mIAA+ | 2524 (40.3) |
ICA+ | 2217 (35.4) |
ZNT8+ | 1635 (26.1) |
AAb ≥2, n (%) | 3606 (57.6) |
HLA–DR3 and/or DR4a, n (%) | 4543 (79.1) |
Dysglycaemia, n (%) | 1462 (23.4) |
BMI, median [IQR] | 19.47 [16.28–24.49] |
Adults aged ≥18, median [IQR], n | 26.09 [23.02–30.77], 1590 |
Children <18, median [IQR], n | 17.39 [15.69–20.61], 4024 |
BMIp, median [IQR] | 52.18 [42.24–61.07] |
Adults aged ≥18, median [IQR], n | 42.61 [23.32–65.50], 1589 |
Children <18, median [IQR], n | 53.26 [46.03–60.47], 4022 |
Age of children <18 with a BMIp, median [IQR], n | 9.62 [6.58–12.82], 4022 |
HOMA-IR, median [IQR] | 1.36 [0.84–2.18] |
Matsuda Index, median [IQR] | 6.56 [4.23–10.26] |
Index60, median [IQR] | 0.04 [−0.69, 0.71] |
IGI, median [IQR] | 0.75 [0.41–1.31] |
aHLA typing information was unavailable for 514 individuals